This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Boehringer Ingelheim Pharma Kg, Neurosearch A/s. Active years: 2003-2012.
Company Filing History:
Years Active: 2003-2012
Title: Andreas Raschig: Innovator in Diabetes and Alzheimer's Research
Introduction
Andreas Raschig is a notable inventor based in Biberach, Germany. He has made significant contributions to the fields of diabetes and Alzheimer's research. With a total of 2 patents, his work focuses on innovative treatments that address critical health issues.
Latest Patents
Raschig's latest patents include groundbreaking inventions aimed at treating type 2 diabetes. One patent relates to the use of a monoamine neurotransmitter re-uptake inhibitor that comprises a 2,3-disubstituted tropane moiety. This invention is designed for the manufacture of a medicament for diabetic patients. Another significant patent involves a muscarinic M1 agonist as an inhibitor of beta-amyloid synthesis. This method aims to lower the levels of beta-amyloid and tau protein in mammals, providing potential treatments for diseases associated with plaque formation.
Career Highlights
Throughout his career, Raschig has worked with prominent companies in the pharmaceutical industry. He has been associated with Boehringer Ingelheim Pharma KG and Neurosearch A/S. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Raschig has collaborated with notable colleagues, including Christoph Hock and Marion Wienrich. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Andreas Raschig is a distinguished inventor whose work in diabetes and Alzheimer's research has the potential to impact many lives. His innovative patents and collaborations reflect his commitment to advancing medical science.